Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group-Reference-Cited by-同舟云学术

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group

Published:2011-07 Issue:11 Volume:47 Page:1676-1681
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Pelzer Uwe,Schwaner Ingo,Stieler Jens,Adler Mathias,Seraphin Jörg,Dörken Bernd,Riess Hanno,Oettle Helmut

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Advanced pancreatic carcinoma: current treatment and future challenges;Stathis;Nat Rev Clin Oncol,2010

2. Cancer statistics;Jemal;CA Cancer J Clin,2009

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

4. First-line chemotherapy in advanced pancreatic cancer;Pelzer;Recent Results Cancer Res,2008

5. Accomplishments in 2008 in the treatment of metastatic pancreatic cancer;Heinemann;Gastrointest Cancer Res,2009

Cited by 310 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Gemcitabine Plus Nab-paclitaxel in Second-line Treatment of Metastatic Pancreatic Cancer: a Multicenter Retrospective Study in Turkey;2024-09-10

2. Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study;Cancer Biology & Medicine;2024-07-26

3. Guidelines for holistic integrative management of pancreatic cancer;Holistic Integrative Oncology;2024-07-08

4. Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab‐paclitaxel plus gemcitabine as second or later‐line treatment;Cancer Medicine;2024-06

5. A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer;Scientific Reports;2024-05-30